Follow RSS for latest reports on this topicBladder Cancer - Market Research and Reports

Bladder Cancer Global Clinical Trials Review, H2, 2018 [Report Updated: 30-11-2018]

Bladder Cancer Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2018 provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries co...Read More >>>

Published:
2018-11-30

Published by: Global Data

Prices Starting From:
$2500

Bladder Pain Global Clinical Trials Review, H2, 2018 [Report Updated: 30-11-2018]

Bladder Pain Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Bladder Pain Global Clinical Trials Review, H2, 2018 provides an overview of Bladder Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted ...Read More >>>

Published:
2018-11-30

Published by: Global Data

Prices Starting From:
$2500

Overactive Bladder - Pipeline Review, H2 2018 [Report Updated: 16-10-2018]

Overactive Bladder - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Pipeline Review, H2 2018, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge m...Read More >>>

Published:
2018-10-16

Published by: Global Markets Direct

Prices Starting From:
$2000

Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Pipeline Review, H2 2018 [Report Updated: 18-09-2018]

Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) - Pipeline Review, H2 2018, provides an overview of the Interstitial Cystitis (Painful Bladder SyndromeBladder Pain Syndrome) (Central Nervous...Read More >>>

Published:
2018-09-18

Published by: Global Markets Direct

Prices Starting From:
$2000

Bladder Cancer - Pipeline Review, H1 2018 [Report Updated: 31-05-2018]

Bladder Cancer - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H1 2018, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one ...Read More >>>

Published:
2018-05-31

Published by: Global Markets Direct

Prices Starting From:
$2500

Overactive Bladder - Pipeline Review, H1 2018 [Report Updated: 30-04-2018]

Overactive Bladder - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Pipeline Review, H1 2018, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge m...Read More >>>

Published:
2018-04-30

Published by: Global Markets Direct

Prices Starting From:
$2000

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2018 [Report Updated: 30-03-2018]

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2018 provides an overview of Muscle Invasive Bladder Cancer (MIBC) clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC). R...Read More >>>

Published:
2018-03-30

Published by: Global Data

Prices Starting From:
$2500

Bladder Cancer: Dynamic Market Forecast to 2026 [Report Updated: 29-03-2018]

Bladder Cancer: Dynamic Market Forecast to 2026SummaryBladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the bladder cancer space, including regulatory, commercial, and clinical events as well as understand how all of these events will impact...Read More >>>

Published:
2018-03-29

Published by: Global Data

Prices Starting From:
$8495

Global Bladder Cancer Partnering 2012 to 2018 [Report Updated: 01-03-2018]

• Insight into key deal terms included in contracts, Read More >>>

Published:
2018-03-01

Published by: Current Partnering

Prices Starting From:
$1495

Bladder Pain - Pipeline Insight, 2018 [Report Updated: 14-02-2018]

Bladder Pain - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bladder Pain development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, ass...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$1250

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2018 [Report Updated: 14-02-2018]

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2018” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Non Muscle Invasive Bladder Cancer development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete p...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$1250

Bladder cancer -Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

DelveInsight's Bladder cancer - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Bladder cancer epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• Japan Study Period: 2016-2027 Bladder cancer Epidemiology...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$3250

Bladder cancer - Market Insight, Epidemiology and Market Forecast - 2027 [Report Updated: 14-02-2018]

DelveInsight's Bladder cancer - Market Insight, Epidemiology and Market Forecast - 2027 report provides a detailed analysis of the Bladder cancer epidemiology and market outlook for the 7MM.Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• JapanStudy Period: 2016-2027Bladder cancer Understanding and Treatment AlgorithmThe market report provides...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$6250

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 [Report Updated: 22-12-2017]

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017SummaryThis report provides an overview of the bladder and ureter pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for these two indications, and features dormant and discontinued projects.Bladder cancer occurs in tissues of the ...Read More >>>

Published:
2017-12-22

Published by: GBI Research

Prices Starting From:
$3995

Bladder Cancer - Pipeline Review, H2 2017 [Report Updated: 30-11-2017]

Bladder Cancer - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H2 2017, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one ...Read More >>>

Published:
2017-11-30

Published by: Global Markets Direct

Prices Starting From:
$2000

Global Superficial Bladder Cancer Drugs Market Research Report Forecast 2017 to 2021 [Report Updated: 20-11-2017]

The Global Superficial Bladder Cancer Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Superficial Bladder Cancer Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and...Read More >>>

Published:
2017-11-20

Published by: S&P Consulting

Prices Starting From:
$2800

Global Bladder Cancer Partnering 2010 to 2017 [Report Updated: 01-11-2017]

• Insight into key deal terms included in contracts, Read More >>>

Published:
2017-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Overactive Bladder - Pipeline Review, H2 2017 [Report Updated: 31-10-2017]

Overactive Bladder - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Pipeline Review, H2 2017, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge m...Read More >>>

Published:
2017-10-31

Published by: Global Markets Direct

Prices Starting From:
$2000

Bladder cancer -Epidemiology Forecast to 2025 [Report Updated: 10-10-2017]

DelveInsight “Bladder cancer - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Bladder cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Bladder cancer prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing ...Read More >>>

Published:
2017-10-10

Published by: Delve Insight

Prices Starting From:
$2750

Bladder cancer - Market Insights, Epidemiology and Market Forecast – 2025 [Report Updated: 10-10-2017]

DelveInsight’s “Bladder cancer - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Bladder cancer - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 201...Read More >>>

Published:
2017-10-10

Published by: Delve Insight

Prices Starting From:
$5750

Bladder Cancer [2017] [Report Updated: 01-08-2017]

How will immune checkpoint inhibitors transform the treatment of Bladder Cancer? Significant progress has been made over the past decade in bladder cancer as a host of new targeted therapies have emerged from the development pipeline. Five PD-1/PD-L1 immune checkpoint inhibitors have been approved but how are they set to impact treatment pathways? Which checkpoint inhibitor do the key opinion lead...Read More >>>

Published:
2017-08-01

Published by: FirstWord Pharma

Prices Starting From:
$8145

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2017 [Report Updated: 31-07-2017]

DelveInsight’s, “Non Muscle Invasive Bladder Cancer-Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Non Muscle Invasive Bladder Cancer. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessme...Read More >>>

Published:
2017-07-31

Published by: Delve Insight

Prices Starting From:
$1250

Overactive Bladder Treatment Market by Pharmacotherapy (Anticholinergic- Solifenacin, Oxybutynin, Fesoterodine, Darifenacin; Mirabegron; BOTOX; Neurostimulation), Disease Type (Idiopathic and Neurogenic Bladder Overactivity) - Global Forecast to 2022 [Report Updated: 27-07-2017]

“Global overactive bladder treatment market is projected to grow at a CAGR of 2.9%.”The global overactive bladder treatment market is estimated to grow at a CAGR of 2.9% from 2017 to 2022, to reach USD 4.19 billion by 2022. The key factors driving the growth of this market include the rising prevalence of overactive bladder (OAB) coupled with the growing geriatric population and rising neurolo...Read More >>>

Published:
2017-07-27

Published by: MarketsandMarkets

Prices Starting From:
$5650

Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicula [Report Updated: 17-07-2017]

The global oncology drugs market was estimated to be around 8 billion as of 2016. The oncology drugs market market made up around 11% Read More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Bladder Pain - Pipeline Insight, 2017 [Report Updated: 10-07-2017]

DelveInsight’s, “ Bladder Pain -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Bladder Pain. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Bladder Pain. This report provides information on the therapeutic development for Bladder Pain, dealing with all the pipe...Read More >>>

Published:
2017-07-10

Published by: Delve Insight

Prices Starting From:
$1250

Bladder Cancer - Pipeline Review, H1 2017 [Report Updated: 13-06-2017]

Bladder Cancer - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H1 2017, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one ...Read More >>>

Published:
2017-06-13

Published by: Global Markets Direct

Prices Starting From:
$2000

Cancer Immunotherapy Market by Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others) by End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2014-2022 [Report Updated: 18-05-2017]

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS1.3. KEY MARKET SEGMENT1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.5. ANALYST TOOLS AND MODELSCHAPTER 2 EXECUTIVE SUMMARY2.1. KEY FINDINGS OF THE STUDY2.2. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. KEY FINDINGS3.2.1. Top investment pockets3.2.2. Top winning strategies3.3....Read More >>>

Published:
2017-05-18

Published by: Allied Market Research

Prices Starting From:
$5370

Overactive Bladder - Pipeline Review, H1 2017 [Report Updated: 09-05-2017]

Overactive Bladder - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Pipeline Review, H1 2017, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge m...Read More >>>

Published:
2017-05-09

Published by: Global Markets Direct

Prices Starting From:
$2000

Bladder Cancer Global Clinical Trials Review, H1, 2017 [Report Updated: 30-04-2017]

Bladder Cancer Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H1, 2017 provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries co...Read More >>>

Published:
2017-04-30

Published by: Global Data

Prices Starting From:
$2500

Bladder Pain Global Clinical Trials Review, H1, 2017 [Report Updated: 30-04-2017]

Bladder Pain Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, “Bladder Pain Global Clinical Trials Review, H1, 2017 provides an overview of Bladder Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted ...Read More >>>

Published:
2017-04-30

Published by: Global Data

Prices Starting From:
$2500

OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2025 [Report Updated: 05-04-2017]

OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2025SummaryThe bladder cancer market in the seven major pharmaceutical markets (US, France, Germany, Italy, Spain, UK, and Japan) has remained largely unchanged in the past 10-20 years. However, significant expansion is expected starting in 2016, with the introduction of several new therapies that are projected to fuel mar...Read More >>>

Published:
2017-04-05

Published by: Global Data

Prices Starting From:
$10995

Overactive Bladder Forecast in 12 Major Markets 2017-2027 [Report Updated: 01-03-2017]

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Overactive Bladder in 12 Major MarketsOveractive Bladder (OAB) is a (relatively) common, disabling condition associated with significant negative impact on quality of life, sleep and mental health. It is characterised as a sudden, strong uncontrollable urge to urinate. This report provides the current prevalent population for Ov...Read More >>>

Published:
2017-03-01

Published by: Black Swan Analysis

Prices Starting From:
$6100

Global Bladder Scanners Market 2012- 2022 [Report Updated: 01-03-2017]

SummaryBased on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type 2D 3DBased on region, the report describes major regions market by vendor, products and application. Regions mentioned as follows: North America Europe Asia RoWBased on application, the report describes major application share of regional marke...Read More >>>

Published:
2017-03-01

Published by: HeyReport

Prices Starting From:
$1920

Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecules (Genetic Biomarkers, Protein Biomarkers, and Glycoprotein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Other Cancers), Application (Diagnostics, Drug Discovery and Development, Prognosti [Report Updated: 01-12-2016]

Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indicat...Read More >>>

Published:
2016-12-01

Published by: Allied Market Research

Prices Starting From:
$5370

Global Bladder Cancer Partnering 2010 to 2016

Published:
2016-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016 provides an overview of Muscle Invasive Bladder Cancer (MIBC) clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC). R...Read More >>>

Published:
2016-10-31

Published by: Global Data

Prices Starting From:
$2500

Bladder Cancer Forecast in 18 Major Markets 2016-2026 [Report Updated: 01-05-2016]

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Bladder Cancer in 18 Major MarketsBladder Cancer is cancer arising in the urinary bladder, generally from urothelial cells. It is the fourth most common cancer in males and the ninth most common in females. While Bladder Cancer is associated with significant morbidity and mortality, prognosis tends to be good with 80-100% surviv...Read More >>>

Published:
2016-05-01

Published by: Black Swan Analysis

Prices Starting From:
$6100

Cancer Immunotherapy Market: By Cancer Type (Cancer Monoclonal Antibodie, Immune Checkpoint Inhibitors, Cancer Vaccines, Non-Specific Immunotherapies & Others) & Geography-Forecast (2016-2021) [Report Updated: 26-02-2016]

Immunotherapy is also known as biologic therapy for cancer treatment. Immunotherapy is treatment which is carried out using certain parts of a person’s immune system to fight diseases such as cancer. Immunotherapy is can be done in two ways which includes either stimulating person’s own immune system to work harder or smarter to attack cancer cells or injecting immune system components, such a...Read More >>>

Published:
2016-02-26

Published by: Industry ARC

Prices Starting From:
$5250

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021) [Report Updated: 22-01-2016]

An alpha-fetoprotein (AFP) test is a blood test that measures the amount of AFP present in blood. It’s usually part of what’s called a triple screen or quad screen in the second trimester of pregnancy. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. The yolk sac and immature liver of an unborn baby produce AFP which then circulates through the fetal ...Read More >>>

Published:
2016-01-22

Published by: Industry ARC

Prices Starting From:
$5250

Bladder Pain Global Clinical Trials Review, H2, 2015

Bladder Pain Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Bladder Pain Global Clinical Trials Review, H2, 2015 provides an overview of Bladder Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted ...Read More >>>

Published:
2015-12-16

Published by: Global Data

Prices Starting From:
$2500